MedTrace Logo

Arrhythmia Detection After MI

NCT05073419 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-07-16

No results posted yet for this study

Summary

Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.

Conditions

  • Acute Myocardial Infarction

Interventions

OTHER

Standard of Care

Routine monitoring of post AMI patient with clinic visits

DEVICE

ICM Implantation

Implantation of ICM through small incision (2 mm) under the skin

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Samir Saba

    lead OTHER

Principal Investigators

  • Samir F Saba, MD · University of Pittsburgh Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-09
Primary Completion
2026-10-31
Completion
2026-10-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05073419 on ClinicalTrials.gov